Radiotherapy for inoperable non-small cell lung cancer using helical tomotherapy

Tumori

Volumn 98, Issue 1, 2012, Pages 86-89

  Monaco, Alessia ^a   Caruso, Cristina ^a   Giammarino, Daniela ^a   Cianciulli, Michele ^a   Pressello, Maria Cristina ^a   Donato, Vittorio ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Lung cancer; Radiotherapy; Tomotherapy

Indexed keywords

CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MALE; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; TOMOTHERAPY; TREATMENT RESPONSE; TUMOR LOCALIZATION; ADJUVANT THERAPY; CHEMORADIOTHERAPY; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; ESOPHAGUS; HOSPITALIZATION; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; RADIATION EXPOSURE; RADIATION INJURY; RADIATION RESPONSE; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; ESOPHAGUS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, SPIRAL COMPUTED; TREATMENT OUTCOME;

EID: 84863215222     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161209800111     Document Type: Article

References (20)

1. Le Chevalier T, Arriagada R, Quoix E, Ruffie P, Martin M, Tarayre M, Lacombe-Terrier MJ, Douillard JY, Laplanche A: Radiotherapy alone vs combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst, 83: 417-423, 1991.
2. Cox JD, Azarnia N, Byhardt RW, Shin KH, Emami B, Perez CA: N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 Gy by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys, 20: 7-12, 1991.
3. Hazuka MB, Turrisi AT 3rd, Lutz ST, Martel MK, Ten Haken RK, Strawderman M, Borema PL, Lichter AS: Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysis. Int J Radiat Oncol Biol Phys, 27: 273-284, 1993. (Pubitemid 23304453)
4. Mackie TR, Balog J, Ruchala K, Shepard D, Aldridge S, Fitchard E, Reckwerdt P, Olivera G, McNutt T, Mehta M: Tomotherapy. Semin Radiat Oncol, 9: 108-117; 1999.
5. Mackie TR, Holmes T, Swerdloff S, Reckwerdt P, Deasy JO, Yang J, Paliwal B, Kinsella T: Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys, 20: 1709-1719, 1993. (Pubitemid 24001191)
6. Mehta M, Scrimger R, Mackie R, Paliwal B, Chappell R, Fowler J: A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 49: 23-33, 2001. (Pubitemid 32041273)
7. Aldridge JS, Harari PM, Reckwerdt PJ, Olivera GH, Tomé W, Fink MB, Mackie TR: Development of conformal avoidance tomotherapy in the treatment of head and neck cancer. Radiat Oncol Biol Phys, 45 (suppl 1): 245, 1999.
8. Aldridge JS, Shepard DM, Mackie TR, Reckwerdt PJ: Conformal avoidance radiotherapy. Radiother Oncol 48 (suppl 1): S76, 1998.
9. Donato V, Zurlo A, Bonfili P, Petrongari M: Hypofractionated radiation therapy for inoperable advanced stage lung cancer. Tumori, 85: 174-176, 1998.
10. Woel RT, Munley MT, Hollis D, Fan M, Bentel G, Anscher MS, Shafman T, Coleman RE, Jaszczak RJ, Marks LB: The time course of radiation therapy-induced reductions in regional perfusion: A prospective study with >5 years of follow-up. Int J Radiat Oncol Biol Phys, 52: 58-67, 2002. (Pubitemid 34051310)
11. De Jaeger K, Seppenwoolde Y, Boersma LJ, Muller SH, Baas P, Belderbos JS, Lebesque JV: Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 55: 1331-1340, 2003. (Pubitemid 36338301)
12. Kron T, Grigorov G, Yu E, Wong E, Chen J, Kim B, Lock M, Rodrigues G, Battisita J: Optimisation of radiotherapy delivery and planning time for helical tomotherapy by means of pre-calculated planning parameters. Med Phys, 30: 1938, 2003.
13. Ashamalla H, Rafla S, Parikh K, Mokhtar B, Goswami G, Kambam S, Abdel-Dayem H, Guirguis A, Ross P, Evola A: The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Int J Radiat Oncol Biol Phys, 63: 1016-1023, 2005. (Pubitemid 41505278)
14. Grills IS, Yan D, Black QC, Wong CY, Martinez AA, Kestin LL: Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 67: 709-719, 2007. (Pubitemid 46215884)
15. Ramsey C, Langen K, Kupelian PA, Scaperoth DD, Meeks SL: A technique for adaptive image-guided helical tomotherapy for lung cancer. Int J Radiat Oncol Biol Phys, 64: 1237-1244, 2006.
16. Scrimger RA, Tomé WA, Olivera GH, Reckwerdt PJ, Mehta MP, Fowler JF: Reduction in radiation dose to lung and other normal tissues using helical tomotherapy to treat lung cancer, in comparison to conventional field arrangements. Am J Clin Oncol, 26: 70-78, 2003. (Pubitemid 36205900)
17. Perez CA, Bauer M, Edelstein S, Gillespie BW, Birch R: Impact of tumor control on survival in carcinoma of the lung treated with irradiation. Int J Radiat Oncol Biol Phys, 12: 539-547, 1986. (Pubitemid 16081614)
18. Saunders M, Dische S, Barrett A, Harvey A, Gibson D, Parmar M: Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee. Lancet, 350: 161-165, 1997. (Pubitemid 27303621)
19. Sause W, Kolesar P, Taylor S IV, Johnson D, Livingston R, Komaki R, Emami B, Curran W Jr, Byhardt R, Dar AR, Turrisi A 3rd: Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest, 117: 358-364, 2000. (Pubitemid 30111583)
20. Horiot JC, Bontemps P, van den Bogaert W, Le Fur R, van den Weijngaert D, Bolla M, Bernier J, Lusinchi A, Stuschke M, Lopez-Torrecilla J, Begg AC, Pierart M, Collette L: Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol, 44: 111-121, 1997. (Pubitemid 27345198)